UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolomics and allergy: Opening Pandora’s box

Journal of allergy and clinical immunology, 2020-03, Vol.145 (3), p.782-784

Spertini, François

2020

Volltextzugriff (PDF)

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis

Nature communications, 2017-07, Vol.8 (1), p.16085-16085, Article 16085

2017

Volltextzugriff (PDF)

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease

Annals of the rheumatic diseases, 2018-06, Vol.77 (6), p.840-847

2018

Volltextzugriff (PDF)

Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study

Journal of allergy and clinical immunology, 2016-07, Vol.138 (1), p.162-168

2016

Volltextzugriff (PDF)

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial

The lancet respiratory medicine, 2015-12, Vol.3 (12), p.953-962

2015

Volltextzugriff (PDF)

Supplemental parenteral nutrition improves immunity with unchanged carbohydrate and protein metabolism in critically ill patients: The SPN2 randomized tracer study

Clinical nutrition (Edinburgh, Scotland), 2019-10, Vol.38 (5), p.2408-2416

2019

Volltextzugriff (PDF)

Safety and immunogenicity of immunotherapy with Bet v 1–derived contiguous overlapping peptides

Journal of allergy and clinical immunology, 2014-07, Vol.134 (1), p.239-240.e13

2014

Volltextzugriff (PDF)

Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study

Rheumatology, 2016-10, Vol.55 (10), p.1901-1905

2016

Volltextzugriff (PDF)

Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen

Infection and Immunity, 2005-12, Vol.73 (12), p.8017-8026

2005

Volltextzugriff (PDF)

Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season

Journal of allergy and clinical immunology, 2018-08, Vol.142 (2), p.678-680.e7

2018

Volltextzugriff (PDF)

Secretory IgA Possesses Intrinsic Modulatory Properties Stimulating Mucosal and Systemic Immune Responses

The Journal of immunology (1950), 2005-09, Vol.175 (5), p.2793-2800

2005

Volltextzugriff (PDF)

Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route

The Journal of infection, 2024-08, Vol.89 (2), p.106205, Article 106205

2024

Volltextzugriff (PDF)

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity

Frontiers in immunology, 2020-11, Vol.11, p.586595-586595

2020

Volltextzugriff (PDF)

Targeting of Secretory IgA to Peyer's Patch Dendritic and T Cells after Transport by Intestinal M Cells

The Journal of immunology (1950), 2004-03, Vol.172 (5), p.3026-3033

2004

Volltextzugriff (PDF)

P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine

Frontiers in immunology, 2020-10, Vol.11, p.574330-574330

2020

Volltextzugriff (PDF)

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Nature reviews. Clinical oncology, 2019-09, Vol.16 (9), p.563-580

2019

Volltextzugriff (PDF)

Tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy

Joint, bone, spine : revue du rhumatisme, 2017-10, Vol.84 (5), p.615-619

2017

Volltextzugriff (PDF)

Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study

Arthritis research & therapy, 2018-10, Vol.20 (1), p.239-239, Article 239

2018

Volltextzugriff (PDF)

Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A

Frontiers in immunology, 2020-03, Vol.11, p.412-412

2020

Volltextzugriff (PDF)

Adverse reactions to biologic agents and their medical management

Nature reviews. Rheumatology, 2014-10, Vol.10 (10), p.612-627

2014

Volltextzugriff (PDF)

Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice

Vaccine, 2016-03, Vol.34 (13), p.1566-1574

2016

Volltextzugriff (PDF)

Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial

AIDS (London), 2014-07, Vol.28 (12), p.1769-1781

2014

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(263)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Humans
(116)
Life Sciences & Biomedicine
(113)
Female
(62)
Immunology
(59)
Adult
(53)
Male
(43)
Middle Aged
(37)
Biological And Medical Sciences
(34)
Animals
(30)
Medical Sciences
(24)
Allergy
(19)
Aged
(18)
Adolescent
(17)
Immunotherapy
(17)
Life Sciences
(17)
Mice
(17)
Rheumatology
(16)
Fundamental And Applied Biological Sciences. Psychology
(15)
Infectious Diseases
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolomics and allergy: Opening Pandora’s box

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease

Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial

Supplemental parenteral nutrition improves immunity with unchanged carbohydrate and protein metabolism in critically ill patients: The SPN2 randomized tracer study

Safety and immunogenicity of immunotherapy with Bet v 1–derived contiguous overlapping peptides

Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study

Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen

Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season

Secretory IgA Possesses Intrinsic Modulatory Properties Stimulating Mucosal and Systemic Immune Responses

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity

Targeting of Secretory IgA to Peyer's Patch Dendritic and T Cells after Transport by Intestinal M Cells

P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy

Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study

The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers

Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A

Adverse reactions to biologic agents and their medical management

Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice

Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial

Suchergebnisse filtern